Wallace H. Coulter Foundation



Through the Columbia-Coulter Translational Research Partnership, selected teams receive funding and guidance to advance promising biomedical technology ideas from conception to proof-of-concept. The Partnership aims to better position these ideas for partnering with a commercial entity that will invest the necessary resources to bring the concept to market.

Information Sessions
For those interested applying for the program, we host Information Sessions each Fall to review the application process, eligibility and evaluation criteria, and how the Partnership works with teams to facilitate the translational research process. Specific dates will be posted here.


The Partnership is led by the Department of Biomedical Engineering at the Fu Foundation School of Engineering and Applied Science, in collaboration with the Departments of SurgeryOrthopaedic Surgery and Radiology at Columbia University Medical Center, and Columbia Technology Ventures, the technology transfer office of Columbia University.  This program is made possible by a generous grant from the Wallace H. Coulter Foundation and support of leadership from the Offices of the Executive Vice President for Research and the Provost.

ELIGIBILITY: Eligible teams must include an engineer, preferably from Columbia’s Fu Foundation School of Engineering and Applied Science with an affiliation to the Department of Biomedical Engineering, and a practicing clinician, preferably with an appointment at Columbia University Medical Center. If you need an engineering or clinical collaborator, we may be able to facilitate introductions. All technologies that may have a direct impact on human health will be considered (e.g. therapeutic drugs and devices, medical imaging, monitoring devices, biosensors, biomaterials, and platform technologies, etc.).  However, the most relevant are those where time to market can be achieved in less than 10 years.

All members of the team should be committed to commercialization objectives and be open to receiving mentorship, coaching, and oversight of their projects.

Projects that propose to undertake discovery research will not be selected. Successful proposals must be translational in nature, i.e. they must focus on efforts to translate research results into practical clinical application. Visit for a description of projects funded in previous cycles

If you received an award from the Partnership in previous years, you may be eligible to apply for additional funding to support your project. Such additional funding is contingent on successful achievement of your previous milestones and demonstration of compelling market feedback requiring additional technical development, among other factors. To explore further, please contact us at

APPLICATION PROCESS: The application process is multi-stage, starting with the submission of a Pre-Proposal.

Selected Pre-Proposals are invited to participate in a multi-session Boot Camp. Teams then submit Full Proposals and “pitch” their projects to a panel of experts comprised of clinicians, biomedical entrepreneurs, early-stage investors, and technology transfer specialists, who evaluate projects on the basis of their potential health care and patient care impact, timeline and pathway to commercialization, technical feasibility, and, most importantly, their potential for obtaining further financial investment to bring the proposed solution to the bedside.